Orreco Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Private

  • Employees
  • 48

Employees

  • Latest Deal Type
  • Series A1

  • Latest Deal Amount
  • $3.71M

  • Investors
  • 29

Orreco General Information

Description

Provider of bio-analytics products and services intended to deliver optimized athlete performance. The company's services are provided through a cognitive platform for sports that includes physiological and biomarker data, assisting coaches to ask performance-related questions and receive evidence-based answers that reveal insights into how players can improve performance, enabling players to reduce the incidence of illness and injury.

Contact Information

Website
www.orreco.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Healthcare Technology Systems
Other Industries
Other Healthcare Services
Corporate Office
  • Unit 103, Business Innovation Centre NUI, Galway
  • Newcastle Road
  • Galway H91 RW53
  • Ireland
+353 (071) 000 0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Orreco Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series A1) 23-Dec-2020 $3.71M 00.00 000.00 Completed Generating Revenue
4. Later Stage VC 27-Sep-2019 00.000 Completed Generating Revenue
3. Later Stage VC (Series A) 14-Feb-2017 00.000 00.000 000.00 Completed Generating Revenue
2. Seed Round 27-Sep-2015 $2.5M $3.62M Completed Generating Revenue
1. Angel (individual) 09-Mar-2015 $1.12M $1.12M Completed Generating Revenue
To view Orreco’s complete valuation and funding history, request access »

Orreco Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
A Ordinary 00,000 00.000000 000.00 000.00 00 000.00 0.000
Series A Preference 00,000 00.000000 000.00 000.00 00 000.00 0.000
Series A Preference 0,000 00.000000 000.00 000.00 00 000.00 0.000
A Ordinary 0,000 00.000000 000.00 000.00 00 000.00 0.000
A Ordinary 00,000 00.000000 000.00 000.00 00 000.00 0.00
A Ordinary 000 00.000000 000.0 000.0 00 000.0 0.00
A Ordinary 0,000 00.000000 000.0 000.0 00 000.0 0.000
Series A Preference 00,000 00.000000 000.00 000.00 00 000.00 0.000
Series A Preference 33,753 $0.001000 $54.61 $54.61 1x $54.61 3.98%
Series A Preference 4,883 $0.001000 $40.96 $40.96 1x $40.96 0.58%
To view Orreco’s complete cap table history, request access »

Orreco Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Provider of bio-analytics products and services intended to deliver optimized athlete performance. The company's service
Other Healthcare Technology Systems
Galway, Ireland
48 As of 2023
00.00
00.00 0000-00-00
00000000000 00.00

00000

ris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehende
00000000000000000000
Palo Alto, CA
00 As of 0000
000.00
00000000000 000.00

000000

reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Ex
00000 0000000 000 00
Bradbury, CA
00 As of 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Orreco Competitors (2)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Zone7 Venture Capital-Backed Palo Alto, CA 00 000.00 00000000000 000.00
BioStrap Corporation Bradbury, CA 00
You’re viewing 2 of 2 competitors. Get the full list »

Orreco Patents

Orreco Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20180249966-A1 Systems and methods to track and manage individualized redox homeostasis Inactive 28-Feb-2017 0000000000
AU-2017201400-A1 Systems and methods to track and manage individualized redox homeostasis Inactive 28-Feb-2017
AU-2018201457-A1 Systems and methods to track and manage individualized redox homeostasis Inactive 28-Feb-2017
CA-2996778-A1 Systems and methods to track and manage individualized redox homeostasis Pending 28-Feb-2017 00000000
CA-2959740-A1 Systems and methods to track and manage individualized redox homeostasis Pending 28-Feb-2017 G16B5/20
To view Orreco’s complete patent history, request access »

Orreco Executive Team (6)

Name Title Board Seat Contact Info
Brian Moore Ph.D Co-Founder, Chief Executive Officer & Board Member
Charles Pedlar Ph.D Chief Science and Research Officer & Sports Scientist
Andrew Hodgson Co-Founder & Clinical Director
Andrew Barr Ph.D High Performance And Movement Specialist
Ara Suppiah Sports Medicine Physician
You’re viewing 5 of 6 executive team members. Get the full list »

Orreco Board Members (6)

Name Representing Role Since
Brian Moore Ph.D Orreco Co-Founder, Chief Executive Officer & Board Member 000 0000
Joe Dumars Self Board Member 000 0000
Keith Wood Orreco Board Member 000 0000
Peter Killalea Self Board Member 000 0000
Philip Black True Ventures Board Member 000 0000
You’re viewing 5 of 6 board members. Get the full list »

Orreco Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Orreco Investors (29)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Andres Delgado Angel (individual) Minority 000 0000 000000 0
David Jones Angel (individual) Minority 000 0000 000000 0
Des Traynor Angel (individual) Minority 000 0000 000000 0
EGR Partners Family Office Minority 000 0000 000000 0
Eran Arkin Angel (individual) Minority 000 0000 000000 0
You’re viewing 5 of 29 investors. Get the full list »

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »